Comparison of Apidra to Regular Insulin in Hospitalized Patients
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare Apidra (a rapid acting insulin analogue) with Regular
insulin (fast acting) in addition to the use of long acting insulin Glargine in hospitalized
patients in terms of efficacy and safety in blood glucose control and frequency of low blood
glucose. Blood glucose control along with incidence and rate of low blood glucose during the
hospitalization shall be of primary interest; length of hospital stay comparing the short
acting insulin used shall be the secondary interest.